RTTNews BiotechCodex · 实盘不做把握 3/10
北京时间·🕒 发布 22:32:07时区推断·⟳ 抓取 22:45:20·⚡ 决策 08-05 23:04:24 +19m04s·82.9 天前
CVS推出29美元线上减重问诊并加强GLP-1药房服务
这更像CVS对既有GLP-1药房与MinuteClinic服务的营销和定价更新,未披露新增订单、收入分成或可量化利润增量。
📄 原文RTTNews Biotech↗ 原文
CVS Health Launches $29 Digital Weight Loss Visits
Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian UK Wallst…
不做 CVS Health(CVS.US)
超大市值主标的的服务营销和价格更新,未披露新增收入、利润或处方量目标,短线无明确正期望。
不做 Eli Lilly(LLY.US)
渠道合作不等于新增药品需求或供给改善,且对礼来市值量级太小,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-05 · 扩散 low · price-in 风险 medium ↗
关键理由
- 这更像CVS对既有GLP-1药房与MinuteClinic服务的营销和定价更新,未披露新增订单、收入分成或可量化利润增量。
- 对礼来只是Zepbound等药品的渠道便利性改善,不改变药品需求、定价或产能约束的核心预期。
主要风险
- 若后续披露CVS与礼来存在排他性渠道、显著返点或新增处方量目标,才可能重新评估。
- 线上减重问诊降价可能对小型远程医疗减重平台形成竞争压力,但本条没有点名可量化受损标的。
原文全文
展开原文 · 8,323 字
CVS Health Launches $29 Digital Weight Loss Visits
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Biotech Daily Dose
By
TajSabreen Ahamed
✉
|
Published:
8/5/2026 10:32 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
CVS Health Corp. (
CVS
) announced new enhancements to its weight management program, aimed at improving access, affordability, and support for patients using GLP-1 medications. The initiative combines digital care, pharmacy access, and clinician support into one connected experience, making treatment more straightforward for eligible adults.
Program Highlights
-CVS Pharmacy now offers all FDA-approved GLP-1 medications, available through insurance or cash-pay options.
-A new collaboration with Eli Lilly will provide eligible Zepbound and Foundayo patients transparent pricing and same-day pickup at CVS Pharmacy locations via the CVS Health app.
-MinuteClinic digital weight loss visits have been lowered to $29, the most affordable option in the market, available 24/7 with no membership or recurring fees.
-Patients can connect with licensed clinicians online, receive prescriptions when clinically appropriate, and pick up medications at over 9,000 CVS Pharmacy locations.
Affordability Measures
CVS Pharmacy accepts third-party discount cards, manufacturer coupons, and vouchers to reduce out-of-pocket costs. Eligible patients may pay as little as $25 per month with insurance and manufacturer coupons, or $149 per month without insurance using vouchers.
CVS also participates in the CMS Medicare GLP-1 Bridge program, offering certain medications for $50 per month to qualifying beneficiaries through 2027.
Company Perspective
Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness, emphasized that weight management is a personal
health
journey often hindered by barriers. He noted that CVS Health's integrated model— combining clinical care, pharmacy access, digital tools, and pharmacist support— simplifies the process and makes treatment more affordable.
Broader Impact
With nearly half of consumers prioritizing personalized pharmacy care and 80% preferring face-to-face engagement, CVS is positioning pharmacists at the center of care. The company's expanded offerings aim to help patients start and stay on GLP-1 therapy, reinforcing CVS Health's role as a leading health solutions provider.
CVS has traded between $62.52 and $110.68 over the past year. The stock is currently trading at $98.46, down 5.72%.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Latest Updates on Middle East War
Strait To Be Open Very Soon Or Iran Will Be Hit Very Hard: Trump
August 05, 2026 07:08 ET
Crude Oil Nosedives Amid Prospects Of U.S.-Iran Deal, Reopening Of Strait Of Hormuz
August 04, 2026 14:32 ET
Gold Surges As Investors Parse Fed's Interest Rate Decision Amid Middle East Tensions
July 30, 2026 13:37 ET
Canadian Stocks Surge Amid Increasing Signals Of Middle East Peace
August 04, 2026 16:28 ET
U.S. Dollar Ticked Higher As Tumbling Crude Oil Prices Ease Inflationary Pressures
August 03, 2026 16:59 ET
View More
Global Economics Weekly Update - July 27 – July 31, 2026
August 01, 2026 02:10 ET
Major central banks, led by the U.S. Federal Reserve, and preliminary estimates of second quarter economic growth dominated the economics news flow this week. In the U.S., the Federal Reserve announced its latest policy decision and early estimates of second quarter growth and monthly inflation data were also released. In Europe, the interest rate decision from the Bank of England was in focus. Similarly, the Bank of Japan was in the limelight in Asia for its policy announcement.
View More Videos
RELATED NEWS
CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains
CVS Health Q2 26 Earnings Conference Call At 8:00 AM ET
CVS Health Corp. Q2 Income Rises
CVS Health To Sell Pet Medications At Its Pharmacies
CVS Caremark Reaches Settlement Agreement With FTC Through Rebate Reforms, Transparency Commitments
Latest Updates on COVID-19
Editor's Pick
Most Read
Most Emailed
Disney Q3 Pre-tax Income Climbs, Backs FY26, FY27 Outlook; Lifts Buyback Plan; Shares Up
August 05, 2026 09:35 ET
Eli Lilly Boosts FY26 Revenue Outlook; Stock Up 5.2% - Update
August 05, 2026 07:22 ET
August 05, 2026 07:10 ET
Kennametal Sees Growth In FY27; Stock Up 5.3% - Update
August 05, 2026 06:54 ET
Infineon Q3 Profit Up, Sees Revenue Growth In Q4, Updates FY26 Revenue View On AI Demand; Stock Down
August 05, 2026 03:43 ET
Toyota Q1 Net Profit Climbs, Volume Down; Lifts FY27 View; Plans Up To ¥1 Trln Buyback; Stock Down
August 04, 2026 02:03 ET
Tyson Foods Q3 Profit Surges
August 03, 2026 09:41 ET
Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET
Micron Stock Rises 8% On AI Memory Collaboration With Liqid And PNNL
August 04, 2026 12:34 ET
Hartford To Acquire Equitable's Employee Benefits Business For About $500 Mln In Premium
August 04, 2026 08:21 ET
Southern Company Announces Offering Of $2.15 Bln Of Convertible Senior Notes
August 03, 2026 07:12 ET
Anthropic's AI Training Method Under Scrutiny
July 31, 2026 18:02 ET
East West Ave Acquisition Prices 10 Mln Unit IPO At $10/shr
July 31, 2026 10:00 ET
Bowhead Specialty Agrees To Be Acquired By American Family Mutual Insurance Company For $1.2 Bln
August 03, 2026 08:18 ET
BP Puts North Sea Oil And Gas Business Up For Sale In Major Portfolio Overhaul
July 31, 2026 18:04 ET
Oculis Announces FDA Pre-IND Feedback Regarding Privosegtors Clinical Development Plan
August 03, 2026 05:01 ET
NatWest Q2 Results Climb, Lifts FY26 Income View; Plans Buybacks
July 31, 2026 02:53 ET
Franklin Resources Announces Name Change
July 31, 2026 09:52 ET
LondonMetric, SREIT To Acquire Picton Property In £404 Mln Deal
July 31, 2026 08:00 ET
Clariant H1 Net Income Rises; 2026 Guidance Remains Unchanged
July 31, 2026 03:02 ET
Pan Ocean Q2 Operating Income Climbs On Sales Growth; Stock Up
July 31, 2026 00:42 ET
Nichiden Corp Profit Advances In Q1
LG CNS Q2 Operating Income Declines
July 31, 2026 00:50 ET
Mitsui DM Sugar Co.,Ltd. Q1 Profit Rises
July 31, 2026 03:03 ET
Daito Trust Construction Co.,Ltd. Bottom Line Declines In Q1
July 31, 2026 00:55 ET
Aozora Bank, Ltd. Profit Climbs In Q1
July 31, 2026 03:04 ET
Seatrium Ltd H1 Income Climbs
July 31, 2026 01:07 ET
OMV AG Announces Increase In Q2 Bottom Line
Holcim H1 Profit Edges Up, Recurring EBIT & Margin Drop; Backs FY26 View
July 31, 2026 01:08 ET
Raiffeisen Bank International H1 Net Income Surges
July 31, 2026 03:06 ET
DENSO Corporation Profit Drops In Q1
July 31, 2026 01:10 ET
Editors Pick
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Biotech Daily Dose
By
TajSabreen Ahamed
✉
|
Published:
8/5/2026 10:32 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
CVS Health Corp. (
CVS
) announced new enhancements to its weight management program, aimed at improving access, affordability, and support for patients using GLP-1 medications. The initiative combines digital care, pharmacy access, and clinician support into one connected experience, making treatment more straightforward for eligible adults.
Program Highlights
-CVS Pharmacy now offers all FDA-approved GLP-1 medications, available through insurance or cash-pay options.
-A new collaboration with Eli Lilly will provide eligible Zepbound and Foundayo patients transparent pricing and same-day pickup at CVS Pharmacy locations via the CVS Health app.
-MinuteClinic digital weight loss visits have been lowered to $29, the most affordable option in the market, available 24/7 with no membership or recurring fees.
-Patients can connect with licensed clinicians online, receive prescriptions when clinically appropriate, and pick up medications at over 9,000 CVS Pharmacy locations.
Affordability Measures
CVS Pharmacy accepts third-party discount cards, manufacturer coupons, and vouchers to reduce out-of-pocket costs. Eligible patients may pay as little as $25 per month with insurance and manufacturer coupons, or $149 per month without insurance using vouchers.
CVS also participates in the CMS Medicare GLP-1 Bridge program, offering certain medications for $50 per month to qualifying beneficiaries through 2027.
Company Perspective
Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness, emphasized that weight management is a personal
health
journey often hindered by barriers. He noted that CVS Health's integrated model— combining clinical care, pharmacy access, digital tools, and pharmacist support— simplifies the process and makes treatment more affordable.
Broader Impact
With nearly half of consumers prioritizing personalized pharmacy care and 80% preferring face-to-face engagement, CVS is positioning pharmacists at the center of care. The company's expanded offerings aim to help patients start and stay on GLP-1 therapy, reinforcing CVS Health's role as a leading health solutions provider.
CVS has traded between $62.52 and $110.68 over the past year. The stock is currently trading at $98.46, down 5.72%.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Latest Updates on Middle East War
Strait To Be Open Very Soon Or Iran Will Be Hit Very Hard: Trump
August 05, 2026 07:08 ET
Crude Oil Nosedives Amid Prospects Of U.S.-Iran Deal, Reopening Of Strait Of Hormuz
August 04, 2026 14:32 ET
Gold Surges As Investors Parse Fed's Interest Rate Decision Amid Middle East Tensions
July 30, 2026 13:37 ET
Canadian Stocks Surge Amid Increasing Signals Of Middle East Peace
August 04, 2026 16:28 ET
U.S. Dollar Ticked Higher As Tumbling Crude Oil Prices Ease Inflationary Pressures
August 03, 2026 16:59 ET
View More
Global Economics Weekly Update - July 27 – July 31, 2026
August 01, 2026 02:10 ET
Major central banks, led by the U.S. Federal Reserve, and preliminary estimates of second quarter economic growth dominated the economics news flow this week. In the U.S., the Federal Reserve announced its latest policy decision and early estimates of second quarter growth and monthly inflation data were also released. In Europe, the interest rate decision from the Bank of England was in focus. Similarly, the Bank of Japan was in the limelight in Asia for its policy announcement.
View More Videos
RELATED NEWS
CVS Health Lifts FY26 Outlook After Growth In Q2; Stock Gains
CVS Health Q2 26 Earnings Conference Call At 8:00 AM ET
CVS Health Corp. Q2 Income Rises
CVS Health To Sell Pet Medications At Its Pharmacies
CVS Caremark Reaches Settlement Agreement With FTC Through Rebate Reforms, Transparency Commitments
Latest Updates on COVID-19
Editor's Pick
Most Read
Most Emailed
Disney Q3 Pre-tax Income Climbs, Backs FY26, FY27 Outlook; Lifts Buyback Plan; Shares Up
August 05, 2026 09:35 ET
Eli Lilly Boosts FY26 Revenue Outlook; Stock Up 5.2% - Update
August 05, 2026 07:22 ET
August 05, 2026 07:10 ET
Kennametal Sees Growth In FY27; Stock Up 5.3% - Update
August 05, 2026 06:54 ET
Infineon Q3 Profit Up, Sees Revenue Growth In Q4, Updates FY26 Revenue View On AI Demand; Stock Down
August 05, 2026 03:43 ET
Toyota Q1 Net Profit Climbs, Volume Down; Lifts FY27 View; Plans Up To ¥1 Trln Buyback; Stock Down
August 04, 2026 02:03 ET
Tyson Foods Q3 Profit Surges
August 03, 2026 09:41 ET
Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET
Micron Stock Rises 8% On AI Memory Collaboration With Liqid And PNNL
August 04, 2026 12:34 ET
Hartford To Acquire Equitable's Employee Benefits Business For About $500 Mln In Premium
August 04, 2026 08:21 ET
Southern Company Announces Offering Of $2.15 Bln Of Convertible Senior Notes
August 03, 2026 07:12 ET
Anthropic's AI Training Method Under Scrutiny
July 31, 2026 18:02 ET
East West Ave Acquisition Prices 10 Mln Unit IPO At $10/shr
July 31, 2026 10:00 ET
Bowhead Specialty Agrees To Be Acquired By American Family Mutual Insurance Company For $1.2 Bln
August 03, 2026 08:18 ET
BP Puts North Sea Oil And Gas Business Up For Sale In Major Portfolio Overhaul
July 31, 2026 18:04 ET
Oculis Announces FDA Pre-IND Feedback Regarding Privosegtors Clinical Development Plan
August 03, 2026 05:01 ET
NatWest Q2 Results Climb, Lifts FY26 Income View; Plans Buybacks
July 31, 2026 02:53 ET
Franklin Resources Announces Name Change
July 31, 2026 09:52 ET
LondonMetric, SREIT To Acquire Picton Property In £404 Mln Deal
July 31, 2026 08:00 ET
Clariant H1 Net Income Rises; 2026 Guidance Remains Unchanged
July 31, 2026 03:02 ET
Pan Ocean Q2 Operating Income Climbs On Sales Growth; Stock Up
July 31, 2026 00:42 ET
Nichiden Corp Profit Advances In Q1
LG CNS Q2 Operating Income Declines
July 31, 2026 00:50 ET
Mitsui DM Sugar Co.,Ltd. Q1 Profit Rises
July 31, 2026 03:03 ET
Daito Trust Construction Co.,Ltd. Bottom Line Declines In Q1
July 31, 2026 00:55 ET
Aozora Bank, Ltd. Profit Climbs In Q1
July 31, 2026 03:04 ET
Seatrium Ltd H1 Income Climbs
July 31, 2026 01:07 ET
OMV AG Announces Increase In Q2 Bottom Line
Holcim H1 Profit Edges Up, Recurring EBIT & Margin Drop; Backs FY26 View
July 31, 2026 01:08 ET
Raiffeisen Bank International H1 Net Income Surges
July 31, 2026 03:06 ET
DENSO Corporation Profit Drops In Q1
July 31, 2026 01:10 ET
Editors Pick
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。